Cargando…
Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone
BACKGROUND: Licorice is an herb extensively used for both culinary and medicinal purposes. Various constituents of licorice have been shown to exhibit anti-tumorigenic effect in diverse cancer types. However, majority of these studies focus on the aspect of their growth-suppressive role. In this stu...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171243/ https://www.ncbi.nlm.nih.gov/pubmed/30285892 http://dx.doi.org/10.1186/s13046-018-0902-4 |
_version_ | 1783360758447341568 |
---|---|
author | Chen, Changliang Shenoy, Anitha K. Padia, Ravi Fang, Dongdong Jing, Qing Yang, Ping Su, Shi-Bing Huang, Shuang |
author_facet | Chen, Changliang Shenoy, Anitha K. Padia, Ravi Fang, Dongdong Jing, Qing Yang, Ping Su, Shi-Bing Huang, Shuang |
author_sort | Chen, Changliang |
collection | PubMed |
description | BACKGROUND: Licorice is an herb extensively used for both culinary and medicinal purposes. Various constituents of licorice have been shown to exhibit anti-tumorigenic effect in diverse cancer types. However, majority of these studies focus on the aspect of their growth-suppressive role. In this study, we systematically analyzed known licorice’s constituents on the goal of identifying component(s) that can effectively suppress both cell migration and growth. METHODS: Effect of licorice’s constituents on cell growth was evaluated by MTT assay while cell migration was assessed by both wound-healing and Transwell assays. Cytoskeleton reorganization and focal adhesion assembly were visualized by immunofluorescence staining with labeled phalloidin and anti-paxillin antibody. Activity of Src in cells was judged by western blot using phosphor-Src416 antibody while Src kinase activity was measured using Promega Src kinase assay system. Anti-tumorigenic capabilities of isoliquiritigenin (ISL) and 2, 4, 2′, 4’-Tetrahydroxychalcone (THC) were investigated using lung cancer xenograft model. RESULTS: Using a panel of lung cancer cell lines, ISL was identified as the only licorice’s constituent capable of inhibiting both cell migration and growth. ISL-led inhibition in cell migration resulted from impaired cytoskeleton reorganization and focal adhesion assembly. Assessing the phosphorylation of 141 cytoskeleton dynamics-associated proteins revealed that ISL reduced the abundance of Tyr421-phosphorylation of cortactin, Tyr925- and Tyr861-phosphorylation of FAK, indicating the involvement of Src because these sites are known to be phosphorylated by Src. Enigmatically, ISL inhibited Src in cells while displayed no effect on Src activity in cell-free system. The discrepancy was explained by the observation that THC, one of the major ISL metabolite identified in lung cancer cells abrogated Src activity both in cells and cell-free system. Similar to ISL, THC deterred cell migration and abolished cytoskeleton reorganization/focal adhesion assembly. Furthermore, we showed both ISL and THC suppressed in vitro lung cancer cell invasion and in vivo tumor progression. CONCLUSION: Our study suggests that ISL inhibits lung cancer cell migration and tumorigenesis by interfering with Src through its metabolite THC. As licorice is safely used for culinary purposes, our study suggests that ISL or THC may be safely used as a Src inhibitor. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0902-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6171243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61712432018-10-10 Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone Chen, Changliang Shenoy, Anitha K. Padia, Ravi Fang, Dongdong Jing, Qing Yang, Ping Su, Shi-Bing Huang, Shuang J Exp Clin Cancer Res Research BACKGROUND: Licorice is an herb extensively used for both culinary and medicinal purposes. Various constituents of licorice have been shown to exhibit anti-tumorigenic effect in diverse cancer types. However, majority of these studies focus on the aspect of their growth-suppressive role. In this study, we systematically analyzed known licorice’s constituents on the goal of identifying component(s) that can effectively suppress both cell migration and growth. METHODS: Effect of licorice’s constituents on cell growth was evaluated by MTT assay while cell migration was assessed by both wound-healing and Transwell assays. Cytoskeleton reorganization and focal adhesion assembly were visualized by immunofluorescence staining with labeled phalloidin and anti-paxillin antibody. Activity of Src in cells was judged by western blot using phosphor-Src416 antibody while Src kinase activity was measured using Promega Src kinase assay system. Anti-tumorigenic capabilities of isoliquiritigenin (ISL) and 2, 4, 2′, 4’-Tetrahydroxychalcone (THC) were investigated using lung cancer xenograft model. RESULTS: Using a panel of lung cancer cell lines, ISL was identified as the only licorice’s constituent capable of inhibiting both cell migration and growth. ISL-led inhibition in cell migration resulted from impaired cytoskeleton reorganization and focal adhesion assembly. Assessing the phosphorylation of 141 cytoskeleton dynamics-associated proteins revealed that ISL reduced the abundance of Tyr421-phosphorylation of cortactin, Tyr925- and Tyr861-phosphorylation of FAK, indicating the involvement of Src because these sites are known to be phosphorylated by Src. Enigmatically, ISL inhibited Src in cells while displayed no effect on Src activity in cell-free system. The discrepancy was explained by the observation that THC, one of the major ISL metabolite identified in lung cancer cells abrogated Src activity both in cells and cell-free system. Similar to ISL, THC deterred cell migration and abolished cytoskeleton reorganization/focal adhesion assembly. Furthermore, we showed both ISL and THC suppressed in vitro lung cancer cell invasion and in vivo tumor progression. CONCLUSION: Our study suggests that ISL inhibits lung cancer cell migration and tumorigenesis by interfering with Src through its metabolite THC. As licorice is safely used for culinary purposes, our study suggests that ISL or THC may be safely used as a Src inhibitor. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0902-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-03 /pmc/articles/PMC6171243/ /pubmed/30285892 http://dx.doi.org/10.1186/s13046-018-0902-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Chen, Changliang Shenoy, Anitha K. Padia, Ravi Fang, Dongdong Jing, Qing Yang, Ping Su, Shi-Bing Huang, Shuang Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone |
title | Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone |
title_full | Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone |
title_fullStr | Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone |
title_full_unstemmed | Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone |
title_short | Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone |
title_sort | suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-tetrahydroxychalcone |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171243/ https://www.ncbi.nlm.nih.gov/pubmed/30285892 http://dx.doi.org/10.1186/s13046-018-0902-4 |
work_keys_str_mv | AT chenchangliang suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone AT shenoyanithak suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone AT padiaravi suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone AT fangdongdong suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone AT jingqing suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone AT yangping suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone AT sushibing suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone AT huangshuang suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone |